Neumora Therapeutics Inc
NASDAQ:NMRA
During the last 3 months Neumora Therapeutics Inc insiders have not bought any shares, and sold 82.6k USD worth of shares. The stock price has increased by 62% over this period (open performance analysis).
The last transaction was made on Feb 17, 2026 by Berns Paul L , who sold 34.5k USD worth of NMRA shares.
During the last 3 months Neumora Therapeutics Inc insiders have not bought any shares, and sold 82.6k USD worth of shares. The stock price has increased by 62% over this period (open performance analysis).
The last transaction was made on Feb 17, 2026 by Berns Paul L , who sold 34.5k USD worth of NMRA shares.
Neumora Therapeutics Inc
Glance View
In the bustling world of biopharmaceuticals, Neumora Therapeutics Inc. carves a unique path through the intricacies of neuroscience, specializing in precision medicines for brain diseases. Founded on the convergence of a deep understanding of neurological disorders and cutting-edge data science, Neumora's mission centers around developing targeted therapies that offer hope and clarity to those grappling with complex mental health issues. The company harnesses an impressive integration of human data insights, machine learning tools, and novel biomarker technologies to identify and validate new therapeutic targets. This strategic approach allows Neumora to streamline the drug discovery and development process, ensuring a more precise alignment between therapeutic interventions and the specific needs of patient subtypes. Monetization for Neumora emerges through strategic collaborations, partnerships, and potential commercial sales of its approved therapies. By forming alliances with research institutions and pharmaceutical giants, the company not only enhances its R&D capabilities but also secures vital funding to propel its clinical programs. Furthermore, Neumora's business model may encompass licensing deals, allowing it to monetize its technology and intellectual properties, including proprietary biomarkers and AI-driven discovery platforms. As drug candidates advance through clinical trials and towards regulatory approval, Neumora positions itself to capture market share by addressing unmet needs in the neurology therapeutic landscape, offering innovative solutions in an industry ripe for disruption.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
